Allscripts (MDRX) Misses Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/2/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Equities rebound to close higher as surging Treasury yields recede
- onsemi cuts Synaptics deal price to $5.7B after rival bid
- Wells Fargo names 13 stocks as overweight tactical ideas
- Twilio, Vylor set to join S&P 500 as index reshuffles members
Allscripts announces third quarter 2018 results
November 1, 2018 4:01 PM EDTReported third quarter growth of 16% in GAAP revenue to $522 million, 19% in non-GAAP revenue to $536 millionThird quarter GAAP loss per share of $0.20, growth of 13% in non-GAAP EPS to $0.18Year-to-date growth of 21% in GAAP revenue to $1,562 million, 23% in non-GAAP revenue to $1,590 millionYear-to-date GAAP loss per share of $0.06, growth of 18% in non-GAAP EPS to $0.52
CHICAGO, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three and nine months ended September 30, 2018.
Third... More
